Achieving this should enable further understanding of mechanisms by which the dynamics of this vital low abundance phosphoinositide couples late endolysosomal trafficking and function to TRPML1 activation in health and neurodegenerative disease. This evidence concerns the gene MCOLN1 and neurodegenerative disease.